Evidence reference only. Not medical advice, not a dosing guide, and not a recommendation to use any drug.

<- Home

Search the library

Type a drug and what you want to know, in plain words. Every result is cited and graded.

Semaglutide nausea Tirzepatide heart rate Retatrutide Muscle loss Appetite Liver / MASH

Looking for a dose, or whether to take one of these? This library does not advise on that, by design. For dosing or whether a medicine suits you, speak to a prescriber or pharmacist. For an approved product, follow its official patient leaflet. For urgent symptoms, contact your local emergency or poison service.

Popular starting points. Type a drug and a concern, for example "semaglutide nausea", to search all findings.

Popular drugs

Semaglutide

GLP-1 receptor agonist

99 results + 2 ongoing View profile ->

Tirzepatide

GIP and GLP-1 receptor dual agonist

82 results + 2 ongoing View profile ->

Retatrutide

INVESTIGATIONAL

GIP, GLP-1 and glucagon receptor triple agonist

52 results + 8 ongoing View profile ->

Liraglutide

GLP-1 receptor agonist

35 results View profile ->

Dulaglutide

GLP-1 receptor agonist

23 results View profile ->

Orforglipron

Oral non-peptide GLP-1 receptor agonist

20 results View profile ->

CagriSema

INVESTIGATIONAL

Long-acting amylin analogue combined with GLP-1 receptor agonism

14 results + 1 ongoing View profile ->

Cotadutide

GLP-1 and glucagon receptor dual agonist

14 results View profile ->

Browse by concern

safety-other

GLP-1-based therapies, multi-agent, Semaglutide, Tirzepatide

129 findings Open domain ->

pharmacology

Semaglutide, Tirzepatide, GLP-1-based therapies, multi-agent

67 findings Open domain ->

weight-loss

Dulaglutide, Orforglipron, CagriSema

55 findings Open domain ->

body-composition

GLP-1-based therapies, multi-agent, Retatrutide, Liraglutide

44 findings Open domain ->

Stomach and gut

GLP-1-based therapies, multi-agent, Orforglipron, CagriSema

36 findings Open domain ->

appetite-intake

Retatrutide, Semaglutide, Liraglutide

32 findings Open domain ->

Specific groups of people

Semaglutide, Tirzepatide, GLP-1-based therapies, multi-agent

32 findings Open domain ->

glycaemic

Dulaglutide, Retatrutide, CagriSema

31 findings Open domain ->